Position in QGEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,332,407
New position
Shares Held
133,177
first reported quarter
Ownership
0.065%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Brevan Howard Capital Management LP holds $32,347,391 across 20 Diagnostics & Research names. QGEN ranks #2 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
30,881 | $6,175,891 | |
| 2 | QGEN |
Qiagen N.V.
This page
|
133,177 | $5,332,407 | |
| 3 | DHR |
Danaher Corp /De/
|
21,586 | $4,092,705 | |
| 4 | A |
Agilent Technologies, Inc.
|
35,679 | $4,066,692 | |
| 5 | ADPT |
Adaptive Biotechnologies Corp
|
170,928 | $2,372,480 | |
| 6 | RVTY |
Revvity, Inc.
|
26,071 | $2,284,080 | |
| 7 | SHC |
Sotera Health Co
|
127,142 | $1,823,216 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
7,723 | $1,317,080 |
All Filings in QGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,332,407 | 133,177 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||